- Product Details
Keywords
- Erlotinib hydrochloride
- Erlotinib hydrochloride 99
- Erlotinib HCL
Quick Details
- ProName: Erlotinib hydrochloride
- CasNo: 183319-69-9
- Molecular Formula: C22H24ClN3O4
- Appearance: as description
- Application: Pharmaceutical intermediates
- DeliveryTime: Within 5-7 work days after confirming ...
- PackAge: 100g, 1kg
- Port: Shanghai
- ProductionCapacity: 500 Kilogram/Month
- Purity: 99%
- Storage: cool and dry
- Transportation: by air
- LimitNum: 10 Gram
- Moisture Content: <0.5%
- Impurity: <1%
Superiority
Shanghai, Run-Biotech Co., Ltd is a leading domestic pharmaceutical, biopharmaceutical, and health care products R & D outsourcing services company. As an innovation-driven and customer-focused company, Run Biotech provides a broad and integrated portfolio of services throughout the drug R&D process. Our services are designed to help our worldwide customers shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient outsourcing solutions.
Based on our technical expertise and excellent research facilities, we successfully establish facilities, advanced R & D services technology platform. We will achieve leapfrog all-round development in the field of chemical synthesis, medicinal chemistry, biological and so on.
Run Biotech has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, discovery biology, pharmacology, formulation services, biologics manufacturing services, antibody, biological research reagent manufacturing and sales services.
In Taiwan , Mainland China and Southeast Asia, Run Biotech has its own logistics center, provides the professional, personalized one-stop services, offers a variety of technologies and products and services for the world's major technology and industrial customers.
Details
Product Name: | Erlotinib hydrochloride |
Synonyms: | Erlotinib HCl (OSI-744);Erlotinib hydrochloride, 98.5%;Tarceva, CP-358774;Erlotinib Hydrochloride WS;NSC 718781) HCl;Erlotinib hydrochloride N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride;Erlotinib HCl, >=99%;CP-358774-01 |
CAS: | 183319-69-9 |
MF: | C22H24ClN3O4 |
MW: | 429.9 |
EINECS: | 620-491-0 |
Product Categories: | Tarceva;Antineoplastic;Anti-cancer&immunity;Inhibitors;API;Molecular Targeted Antineoplastic;-;Heterocyclic Compounds;anti-neoplastic;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals |